Total Payments
$654,500
2024 Payments
$68,243
Companies
74
Transactions
2,671
Medicare Patients
3,321
Medicare Billing
$304,828
Payment Breakdown by Category
Other$509,003 (77.8%)
Travel$61,895 (9.5%)
Food & Beverage$61,049 (9.3%)
Consulting$21,804 (3.3%)
Education$689.75 (0.1%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $509,003 | 312 | 77.8% |
| Travel and Lodging | $61,895 | 121 | 9.5% |
| Food and Beverage | $61,049 | 2,182 | 9.3% |
| Consulting Fee | $21,804 | 12 | 3.3% |
| Education | $689.75 | 43 | 0.1% |
| Gift | $59.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $313,804 | 645 | $0 (2024) |
| Amgen Inc. | $90,986 | 174 | $0 (2024) |
| Novo Nordisk Inc | $75,551 | 268 | $0 (2024) |
| Lilly USA, LLC | $42,899 | 184 | $0 (2024) |
| Esperion Therapeutics, Inc. | $29,576 | 81 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23,125 | 122 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $22,421 | 66 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $17,992 | 41 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $7,864 | 21 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $6,183 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68,243 | 159 | AstraZeneca Pharmaceuticals LP ($37,580) |
| 2023 | $120,332 | 321 | Amgen Inc. ($56,043) |
| 2022 | $178,917 | 437 | AstraZeneca Pharmaceuticals LP ($62,974) |
| 2021 | $82,575 | 404 | AstraZeneca Pharmaceuticals LP ($40,686) |
| 2020 | $85,649 | 346 | AstraZeneca Pharmaceuticals LP ($60,098) |
| 2019 | $64,696 | 347 | AstraZeneca Pharmaceuticals LP ($51,752) |
| 2018 | $27,067 | 287 | AstraZeneca Pharmaceuticals LP ($18,063) |
| 2017 | $27,022 | 370 | AstraZeneca Pharmaceuticals LP ($17,402) |
All Payment Transactions
2,671 individual payment records from CMS Open Payments — Page 1 of 107
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Diabetes Care | ||||||
| 12/10/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: PAIN | ||||||
| 09/27/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $102.71 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Obesity | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $27.81 | General |
| Category: GI | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $31.15 | General |
| Category: GI | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: PAIN | ||||||
| 07/30/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 430 | 782 | $139,250 | $41,286 |
| 2022 | 17 | 667 | 1,477 | $253,700 | $71,475 |
| 2021 | 20 | 1,174 | 2,170 | $454,550 | $113,191 |
| 2020 | 18 | 1,050 | 1,858 | $421,500 | $78,876 |
Total Patients
3,321
Total Services
6,287
Medicare Billing
$304,828
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 474 | $70,950 | $31,280 | 44.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 50 | $17,500 | $4,925 | 28.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 25 | 25 | $15,000 | $1,083 | 7.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $2,950 | $1,043 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $2,800 | $739.27 | 26.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 30 | 30 | $4,500 | $635.54 | 14.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 29 | 29 | $3,450 | $593.34 | 17.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 45 | 48 | $14,400 | $454.53 | 3.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 31 | $3,400 | $318.84 | 9.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 22 | $1,100 | $184.80 | 16.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 16 | 30 | $3,200 | $28.77 | 0.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 671 | $100,800 | $46,192 | 45.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 100 | 114 | $39,300 | $14,913 | 37.9% |
| 96374 | Injection of drug or substance into vein | Office | 2022 | 51 | 124 | $14,850 | $4,117 | 27.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 16 | 21 | $4,550 | $1,344 | 29.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 23 | 23 | $14,500 | $1,004 | 6.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 41 | 41 | $6,150 | $923.33 | 15.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $1,900 | $670.51 | 35.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 27 | 27 | $2,700 | $541.89 | 20.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 47 | $14,100 | $479.36 | 3.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 39 | $4,100 | $460.18 | 11.2% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 14 | 70 | $21,000 | $380.35 | 1.8% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 13 | 13 | $3,900 | $278.83 | 7.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 19 | 19 | $950.00 | $56.70 | 6.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 18 | 49 | $4,900 | $55.27 | 1.1% |
About Dr. Bulent Atac, MD
Dr. Bulent Atac, MD is a Internal Medicine healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942375134.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bulent Atac, MD has received a total of $654,500 in payments from pharmaceutical and medical device companies, with $68,243 received in 2024. These payments were reported across 2,671 transactions from 74 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($509,003).
As a Medicare-enrolled provider, Atac has provided services to 3,321 Medicare beneficiaries, totaling 6,287 services with total Medicare billing of $304,828. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bronx, NY
- Active Since 11/22/2006
- Last Updated 08/09/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1942375134
Products in Payments
- FARXIGA (Drug) $251,995
- Repatha (Biological) $87,824
- Rybelsus (Drug) $43,869
- MOUNJARO (Drug) $33,573
- AIRSUPRA (Drug) $31,150
- NURTEC ODT (Drug) $28,918
- NEXLIZET (Drug) $25,657
- JARDIANCE (Drug) $24,955
- Ozempic (Drug) $24,893
- QUVIVIQ (Drug) $17,992
- BYDUREON (Drug) $17,324
- PRALUENT ALIROCUMAB INJECTION (Biological) $7,837
- LOKELMA (Drug) $7,229
- UBRELVY (Drug) $4,743
- NEXLETOL (Drug) $3,834
- Victoza (Drug) $2,265
- Aimovig (Biological) $2,063
- Kerendia (Drug) $1,810
- XIFAXAN (Drug) $1,258
- Vascepa (Drug) $1,229
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bronx
Timothy Kanter, M.d, M.D
Internal Medicine — Payments: $865,160
Internal Medicine $865,160
Dr. Jason Leider, M.d, M.D
Internal Medicine — Payments: $759,257
Internal Medicine $759,257
Shervin Mortazavi, M.d, M.D
Internal Medicine — Payments: $402,598
Internal Medicine $402,598
Dr. Elizabeth Jenny-Avital
Internal Medicine — Payments: $176,355
Internal Medicine $176,355
Vivek Gumaste, M.d, M.D
Internal Medicine — Payments: $163,229
Internal Medicine $163,229
Amit Verma, Md, MD
Internal Medicine — Payments: $128,888
Internal Medicine $128,888